Needs by area

Besoins par zones

Choisissez votre zone de préoccupations

Cheekbones

Contour & Pommettes

Cheekbones

Les effets de l'âge

Affaissement des compartiments graisseux des joues et perte de volume due à la gravité3,5,12

Problème spécifique

Sillons visibles entre les compartiments graisseux qui tombent,2 donnant un regard triste, amer et fatigué6

Attentes vis-à-vis du traitement

Des contours plus nets et sculptés, pour une apparence plus jeune et plus belle2,3,6

Pas de gonflement disgracieux sur le visage (aspect « écureuil »)6

Effet lifting et repulpant naturel6

Résultats durables7 avec peu ou pas d’effets secondaires7,8

Soin

TEOSYAL® PURESENSE ULTRA DEEP

TEOSYAL® PURESENSE ULTRA DEEP9

 

Cheeks

Joues

Cheeks

Les effets de l'âge

Perte de graisse sous-jacente, redistribution de la graisse3,12

Problème spécifique

Creusements, sillons et renfoncements, créant un effet d'épuisement2,6

Attentes vis-à-vis du traitement

Repulpage de la zone creusée et apparence rajeunie2,3

Dynamisme du visage préservé6

Effet lifting naturel et résultats durables7avec peu ou pas d’effets secondaires7,8

Soin

TEOSYAL RHA® 4

TEOSYAL RHA® 411

Smile/laugh lines

Sillons nasogéniens

Smile/laugh lines

Les effets de l'âge

Perte de graisse sous-jacente et d'élasticité de la peau, mouvements répétés des muscles2,4,6

Problème spécifique

Asymétries, sillons plus profonds et relâchement cutané, donnant un aspect triste et fatigué2,6

Attentes vis-à-vis du traitement

Suppression des asymétries et raffermissement de la peau, comblement des sillons marqués2

Dynamisme du visage préservé (pas de sourire figé)6

Rajeunissement naturel6,7 Résultats durables7 avec peu ou pas d’effets secondaires7,8

Soin

TEOSYAL RHA® 3

TEOSYAL RHA® 310

Référence

TEOSYAL RHA® 3, TEOSYAL RHA® 4 and TEOSYAL® PURESENSE ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. TEOSYAL® PURESENSE Ultra Deep exist also without lidocaine : TEOSYAL® ULTRA DEEP. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.

Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas).

General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.

Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.

Please consult your physician or pharmacist for more information.

Please refer to instructions for use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effects or any claim as soon as possible to the following address: medical@teoxane.com.

  1. Emre IE, Cakmak O. Ageing face, an overview – Aetiology, assessment and management. Otorhinolaryngol. 2013;6(3):160-6.
  2. Bass LS. Injectable filler techniques for facial rejuvenation, volumization, and augmentation. Facial Plast Surg Clin North Am. 2015;23(4):479-88.
  3. Gutowski KA. Hyaluronic acid fillers: science and clinical uses. Clin Plast Surg. 2016;43(3):489-96.
  4. Coleman SR, Grover R. The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J. 2006;26(1S):S4-9.
  5. Pao KY, Mancini R. Nonsurgical periocular rejuvenation: advanced cosmetic uses of neuromodulators and fillers. Curr Opin Ophthalmol. 2014;25(5):461-9.
  6. Michaud T, Gassia V, Belhaouari L. Facial dynamics and emotional expressions in facial aging treatments. J Cosmet Dermatol. 2015;14(1):9-21.
  7. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging. 2007;2(3):369-76
  8. TEOXANE DoF 207414-E_ADV-TEOSYAL_UK.pdf (page 56, reference 3: TEOXANE International study 2017)
  9. TEOXANE Data on File. TEOSYAL® PURESENSE ULTRA DEEP Notice
  10. TEOXANE Data on File.Teosyal RHA® 3 Notice.
  11. TEOXANE Data on File.Teosyal RHA® 4 Notice.
  12. Luthra A. Shaping lips with fillers. J Cutan Aesthet Surg. 2015;8(3):139-42.

Find a practitioner

Required fields*

I agree to receive exclusive offers and the latest news from Hyaluronic-acid.com
Choose your country

Fermé

close
Europe

France

UK

Germany

Italy

Poland

Switzerland

International

English

Revenir à l'espace client

Vous entrez dans l'espace professionnel

close